For drugmakers, the best way to pick up steam is to buy smaller companies. Read More

In last week’s Income Without Borders we looked at the odds of Great Britain leaving the European Union, which we handicapped as low. This week we’ll look at the opportunities the situation presents.We know opportunities are coming because we have seen this show before.Greece’s potential exit of the European… Read More

Oil prices have halved in the last six months, and the media are filled with stories of the benefits this is bringing the U.S. economy. Yet when looked at closely, the U.S. economy is only marginally a winner from this move. The real winner, because it produces little of its… Read More

With these shares, you have a broad exposure to one of the world's most successful economies. Read More

While the current spat between Russia and the Europe doesn’t mark a sudden about-face in any nation’s energy policy, it could ultimately create a big market for our glut of natural gas. Read More

Will China's slowing real estate market pull down the overall economy with it? We don't think so, but here are a couple of companies to avoid until we know for sure. Read More

As India inches closer to the election of a new Prime Minister, its stock market is already up 6% this year on expectations that the expected victor will be a friend of big business such as this major drug company. Read More

When index fund managers re-calibrate their holdings, entire markets can quake. Read More

Investor concerns about reporting transparency in China are overblown. Here's some perspective. Read More

Investors who ignore Africa are missing out on huge potential gains. Read More